Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | LLY | Common Stock | Award | $47.9M | +55.1K | +11.38% | $868.88 | 540K | Feb 10, 2025 | Direct | |
holding | LLY | Common Stock | 59.5K | Feb 10, 2025 | By David A. Ricks 2022 GRAT | ||||||
holding | LLY | Common Stock | 68.7K | Feb 10, 2025 | By David A. Ricks SLAT | F1 | |||||
holding | LLY | Common Stock | 300 | Feb 10, 2025 | By Trust | F1 | |||||
holding | LLY | Common Stock | 7.26K | Feb 10, 2025 | 401(k) |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | LLY | Restricted Stock Unit | Award | $0 | +31.9K | $0.00 | 31.9K | Feb 10, 2025 | Common Stock | 31.9K | Direct | F2 |
Id | Content |
---|---|
F1 | The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. |
F2 | Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. |